Beijing Tongrentang Co., Ltd (SHA: 600085)

Market Cap	46.90B
Revenue (ttm)	17.86B
Net Income (ttm)	1.70B
Shares Out	1.37B
EPS (ttm)	1.24
PE Ratio	27.54
Forward PE	28.03
Dividend	0.50 (1.46%)
Ex-Dividend Date	Jun 28, 2024

Volume	4,109,718
Open	34.42
Previous Close	34.43
Day's Range	34.15 - 34.51
52-Week Range	33.38 - 55.74
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally. The company provides product formulations, such as pills, powders, liquors, capsules, oral liquids, and dripping pills in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, tonic and soothe the nerves, digestive system, pediatrics, expelling wind and dampness, orthopedics, five senses, skin surgery, spiritual, and food alcohol diseases. It sells its products under t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 16,777
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2023, 600085's revenue was 17.86 billion, an increase of 16.19% compared to the previous year's 15.37 billion. Earnings were 1.67 billion, an increase of 16.92%.